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Abstract 
The interaction of camitine with human placental brush-border membrane vesicles was investigated. Carnitine was found to associate 
with the membrane vesicles in a Na t-dependent manner. The time course of this association did not exhibit an overshoot, which is typical 
of a Na + gradient-driven transport process. The absolute requirement for Na + was noticeable whether the association of carnitine with 
the vesicles was measured with a short time incubation or under equilibrium conditions, indicating Na+-dependent binding of carnitine to 
the human placental brush-border membranes. The binding was saturable and was of a high-affinity type with a dissociation constant of 
1.37 + 0.03 I~M. Anions had little or no influence on the binding process. The binding process was specific for camitine and its acyl 
derivatives. Betaine also competed for the binding process, but other structurally related compounds did not. Kinetic analyses revealed 
that Na + increased the affinity of the binding process for carnitine and the Na+/camitine coupling ratio for the binding process was 1. 
The dissociation constant for the interaction of Na-- with the binding of carnitine was 24 + 4 mM. This constitutes the first report on the 
identification of Nat-dependent high-affinity camitine binding in the plasma membrane of a mammalian cell. Studies with purified rat 
renal brush-border membrane vesicles demonstrated the presence of Na + gradient-driven carnitine transport but no Nat-dependent 
carnitine binding in these membrane vesicles. In contrast, purified intestinal brush-border membrane vesicles possess neither Na t 
gradient-driven carnitine transport nor Nat-dependent carnitine binding. 
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1. Introduction 
Carnitine ([3-hydroxy-~/-N-trimethylaminobutyrate) is an 
essential cofactor in the oxidation of long-chain fatty acids 
because it facilitates their transport from the cytoplasm 
into the mitochondria cross the inner mitochondrial mem- 
brane [1]. The ability to oxidize fatty acids is extremely 
important for fetal adaptation to extrauterine life because 
during the immediate postnatal period, there is an abrupt 
transition from reliance upon glucose as the main energy 
fuel to fatty acids as the major substrate for energy produc- 
tion. Thus, there is a need for the developing fetus to build 
up the tissue reserves of carnitine in preparation for this 
critical metabolic transition at birth. In adults, carnitine is 
synthesized endogenously using the carbon skeleton of 
lysine and the methyl group of S-adenosyl methionine [2]. 
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Due to this endogenous biosynthetic apacity, there is no 
dietary requirement for carnitine in adult mammals [3]. 
However, available evidence suggests that developing fe- 
tuses and neonates may not be capable of synthesizing 
adequate amounts of camitine despite an adequate supply 
of the necessary precursor amino acids lysine and methion- 
ine due to immature development of the camitine biosyn- 
thetic pathway in the liver and kidney [4-7]. And yet, 
carnitine levels in neonatal and cord blood have been 
found to be significantly higher when compared to mater- 
nal blood [8,9]. The apparent inability of the fetus to 
synthesize camitine and the higher levels of carnitine in 
the fetal circulation than in the maternal circulation sug- 
gest that the placenta is capable of active transfer of 
carnitine from mother to fetus. 
To date, there has been only a single reported study on 
the transport of camitine across the human placenta [10]. 
This study, utilizing an in vitro placental perfusion tech- 
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nique, could not demonstrate concentrative transport of 
carnitine across the placenta from the maternal side to the 
fetal side. This study, however, did show that carnitine is 
taken up by the placental tissue in a stereospecific manner, 
indicating participation of a mediated process. There is no 
information available at present on the identity and nature 
of this mediated process. The present investigation was 
undertaken to delineate the mechanism of carnitine trans- 
port in the placenta t the membrane level rather than at 
the whole organ level. The syncytiotrophoblast, which is 
the primary functional unit of the placenta, is a polarized 
cell with its brush-border membrane in direct contact with 
maternal blood and its basal membrane facing fetal circula- 
tion. Thus, the maternal-facing brush-border membrane 
forms the first barrier between the maternal and fetal 
circulations. It is known that this membrane possesses 
active transport mechanisms for various nutrients which 
are transported in a concentrative manner across the pla- 
centa from mother to fetus [11]. Therefore, we studied the 
interaction of carnitine with purified human placental 
brush-border membrane vesicles in an attempt o under- 
stand the mechanism responsible for active maternal-to- 
fetal transfer of carnitine across the placenta. For compari- 
son, we also studied the interaction of carnitine with 
brush-border membrane vesicles isolated from two other 
transport organs, namely the kidney and the intestine. 
mannitol. Protein concentration in final membrane prepara- 
tions was adjusted to either 5 mg/ml  (carnitine 
transport/binding studies) or 1.5 mg/ml (serotonin trans- 
port studies). The membrane vesicles were stored in small 
aliquots in liquid nitrogen and used within 2-3 weeks of 
preparation. 
2.3. Measurement of transport~binding in membrane 
vesicles 
Transport/binding was initiated by mixing 40 Ixl of 
membrane vesicles with 160 ~zl of transport/binding 
medium containing radiolabeled substrate [16]. The com- 
position of the medium varied depending upon the individ- 
ual experiment. In most cases, the medium was l0 mM 
Hepes-Tris buffer (pH 7.5), containing 150 mM NaC1. The 
mixture was then incubated at room temperature for the 
desired time. At the end of the incubation, transport/bind- 
ing was terminated by the addition of 3 ml of ice-cold 5 
mM Hepes-Tris buffer (pH 7.5) containing 160 mM KC1, 
followed by filtration under vacuum on a Millipore filter 
(DAWP type, 0.65 txm pore size). By this procedure, the 
brush-border membrane vesicles were retained on the fil- 
ter. The filter was washed four times with 5 ml of the same 
KCl-buffer, following which the radioactivity associated 
with the filter was determined by liquid scintillation spec- 
trometry. 
2. Materials and methods 2.4. Data analysis 
2.1. Materials 
L-[methyl-3H]Carnitine (specific radioactivity, 77 
Ci/mmol) was purchased from Amersham. 5-[1,2-3H]Hy - 
droxytryptamine (serotonin) (specific radioactivity, 30.4 
Ci/mmol) was purchased from Du Pont-New England 
Nuclear. L-Carnitine, D-carnitine, acetyl-DL-carnitine, stea- 
royl-oL-carnitine, palmitoyl-oL-carnitine, betaine, y- 
aminobutyrate, [3-hydroxybutyrate, 6-N-trimethyllysine, 
choline, and creatinine were obtained from Sigma. Propi- 
onyl-oL-carnitine was kindly provided by Dr. A.L. Carter 
(Department of Biochemistry and Molecular Biology, 
Medical College of Georgia, Augusta, GA). All other 
chemicals were of analytical grade. 
2.2. Preparation of brush-border membrane vesicles 
The Mg2+-aggregation method [12] was used to isolate 
the maternal-facing brush-border membrane vesicles from 
normal human term placentas obtained within 1 h of 
delivery. Brush-border membrane vesicles from rat renal 
cortical tissue and from rabbit intestinal mucosal tissue 
were prepared as described previously [13-15] by using a 
similar Mg2+-aggregation method. The membrane vesicles 
were preloaded with 10 mM Hepes-Tris buffer (pH 7.5), 
containing 75 mM potassium gluconate and 150 mM 
Measurements were made in duplicate or triplicate and 
each experiment was done with 1-3 different membrane 
preparations. Results are given as means + S.E. Kinetic 
analyses were carried out using a commercially available 
computer software called Fig. P.6.0 (Biosoft, Cambridge, 
UK). 
3. Results 
3.1. Influence of Na + on the transport~binding of carni- 
tine in human placental brush-border membrane vesicles 
Fig. 1 describes the time course of carnitine 
transport/binding in human placental brush-border mem- 
brane vesicles in the presence and absence of an inwardly 
directed Na + gradient. The membrane vesicles were 
preloaded with 10 mM Hepes-Tris buffer (pH 7.5) contain- 
ing 150 mM mannitol and 75 mM potassium gluconate 
and the transport/binding of carnitine was determined in
the presence of KC1 or NaC1 in the extravesicular medium. 
In the absence of Na +, the amount of carnitine associated 
with the membrane vesicles was very small even though it 
increased with time. The presence of Na + in the extraves- 
icular medium markedly increased the amount of carnitine 
that was associated with the membrane vesicles. This 
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Na+-dependent increase was evident at all time periods 
(0.5-240 rain). With a 240 min incubation, the 
transport/binding of carnitine was almost 10-fold greater 
in the presence of Na ÷ than in its absence. 
When placental brush-border membrane vesicles 
preloaded with a Na+-free buffer are mixed with a Na +- 
containing buffer, there exists initially an inwardly directed 
Na ÷ gradient which disappears gradually with time. At 
equilibrium, there is no concentration gradient for Na ÷ 
across the membrane (i.e., [Na+]inside----[Na+]outside). Un- 
der these experimental conditions, Na ÷ gradient-dependent 
transport systems exhibit an 'overshoot' phenomenon in 
which the transport is much greater at shorter periods of 
incubation than at equilibrium. Previous studies from our 
laboratory have demonstrated such an overshoot phe- 
nomenon in human placental brush-border membrane vesi- 
cles for several Na ÷ gradient-dependent transport systems. 
Examples of these transport systems include those which 
transport aurine [17], succinate [18], serotonin [19], and 
catecholamines [20,21]. Therefore, it was interesting that 
even though the association of carnitine with the placental 
brush-border membrane vesicles was Na+-dependent, the 
process did not exhibit an overshoot. To provide evidence 
that an inwardly directed Na + gradient did exist at the 
initial stages of incubation which dissipated with time, we 
studied serotonin transport in these membrane vesicles 
under the same experimental conditions in which carnitine 
transport/binding was measured. As shown in Fig. 2, the 
transport of serotonin in the presence of Na + was many- 
fold greater at 2.5 min incubation than at equilibrium (240 
min incubation), demonstrating the overshoot. Further- 
more, the transport was Na+-dependent at 2.5 rain, but this 
Na+-dependence was not seen at 240 min. These results 
clearly indicate that there was a complete dissipation of the 
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Fig. 1. Time course of carnitine binding to human placental brush-border 
membrane vesicles. Membrane vesicles were preloaded with 10 mM 
Hepes-Tris buffer (pH 7.5), containing 75 mM potassium gluconate and 
150 mM mannitol. Binding of carnitine was initiated by mixing 40 Ixl of 
membrane suspension (200 I.Lg membrane protein) with 160 p.1 of 10 mM 
Hepes-Tris buffer (pH 7.5), containing [3H]carnitine and either 150 mM 
NaC1 (0)  or 150 mM KCI ((3). The mixture was incubated for varying 
time periods and bound carnitine was measured by rapid filtration assay. 
Final concentration f carnitine in the incubation mixture was 10 nM. 
Values represent means :tz S.E. (n = 4). 
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Fig. 2. Influence of Na + on serotonin transport inplacental brush-border 
membrane vesicles. Membrane vesicles were preloaded with 10 mM 
Hepes-Tris buffer (pH 7.5) containing 75 mM potassium gluconate and 
150 mM mannitol. Transport of serotonin was initiated by mixing 40 Ixl 
of membrane suspension (200 &g membrane protein) with 160 p.l of 10 
mM Hepes-Tris buffer (pH 7.5), containing [3H]serotonin a d either 150 
mM NaC1 or 150 mM KC1. The mixture was incubated for either 2.5 min 
or 4 h and the amount of serotonin transported into the vesicles was 
determined by rapid filtration assay. Final concentration f serotonin i  
the incubation mixture was 20 nM. Values represent means +S.E. (n = 3). 
Na ÷ gradient within 240 min incubation. Since the associ- 
ation of carnitine with the membrane vesicles shows an 
obligatory dependence on Na ÷ even under these Na÷-equi - 
libration conditions, this means that the process is depen- 
dent on Na ÷ rather than the transmembrane Na ÷ gradient. 
The intravesicular volume in human placental brush- 
border membrane vesicles is in the range of 1-2 Ix l /mg of 
protein [16,22,23]. If carnitine is sequestered in the intrav- 
esicular space in free form in these membrane vesicles, the 
maximal amount of carnitine that can be expected to be 
associated with the vesicles at equilibrium and at a concen- 
tration of 10 nM is about 0.02 pmol /mg of protein. 
Interestingly, the amount of carnitine associated with the 
vesicles under these conditions is about 1 pmol /mg of 
protein, a value which is 50-times greater than the ex- 
pected value. This indicates that carnitine binds to the 
placental brush-border membrane vesicles and that the 
binding process is Na+-dependent. In order to differentiate 
the binding from the transport, we studied the influence of 
increasing osmolarity in the extravesicular medium on the 
equilibrium association (4 h incubation) of camitine with 
the membrane vesicles in the presence of Na +. It was 
found that osmolarity of the extravesicular medium had 
negligible ffect on the amount of carnitine associated with 
the membrane vesicles (Fig. 3). These results strongly 
suggest hat carnitine binds to the human placental brush- 
border membranes. 
3.2. Ion specificity of carnitine binding 
We studied the influence of various monovalent cations 
and anions on the binding of carnitine to the placental 
brush-border membrane vesicles. In this experiment, the 
vesicles were preloaded with a buffer containing 150 mM 
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Fig. 3. Influence of medium osmolarity on the association of carnitine 
with human placental brush-border membrane vesicles. Membrane vesi- 
cles were preloaded with 10 mM Hepes-Tris buffer (pH 7.5), containing 
75 mM potassium gluconate and 150 mM mannitol. Equilibrium associa- 
tion of [3H]carnitine with the vesicles was measured with a 4 h incuba- 
tion in the media consisting of 10 mM Hepes-Tris (pH 7.5), 60 mM 
NaCI, and varying concentrations of mannitol. Final concentration of 
carnitine in the incubation mixture was 10 nM. The osmolority values of 
the final incubation media were used in the analysis. 
Table 2 
Substrate specifity of camitine binding sites in human placental brush 
border membranes 
Substrate analog [ 3 H]Carnitine binding 
pmol /mg of protein % 
None 0.61 +0.01 100 
L-Camitine 0.05 _ 0.00 9 
~Camitine 0.06 + 0.00 9 
Acetyl-DL-carnitine 0.06 + 0.00 9 
Propionyl-~-carnitine 0.04 + 0.00 7 
Palmitoyl-DL-carnitine 0.07 5:0.00 12 
Stearoyl-DL-carnitine 0.15 ± 0.01 26 
Betaine 0.06 ± 0.00 9 
6-N-Trimethyllysine 0.55 ± 0.00 91 
!3-Hydroxybutyrate 0.65 ± 0.01 106 
~/-Aminobutyrate 0.65 + 0.00 106 
Choline 0.53 _ 0.01 87 
Creatinine 0.53 ± 0.01 87 
Binding of [3H]carnitine (10 nM) to placental brush-border membranes 
was measured with a 4 h incubation in the presence of Na +. Final 
concentration of unlabeled substrate analogs was 100 txM. Values are 
means + S.E. (n = 3). 
mannitol and 75 mM potassium gluconate and the binding 
was measured in buffers containing 120 mM of different 
inorganic salts. The binding was measured with two differ- 
ent incubation periods, 10 min (initial binding) and 4 h 
(equilibrium binding). As is evident in Table 1, the initial 
as well as equilibrium binding was maximal when Na + 
was present, and substitution of Na ÷ with other monova- 
lent cations such as K ÷ and Li ÷ reduced the binding 
considerably. This shows that neither of these two cations 
can effectively substitute for Na + in the binding process. It 
is also evident from the data that the initial rates of 
Na÷-dependent carnitine binding (10 rain incubation) was 
only slightly affected by various anions. However, when 
Table 1 
Influence of monovalent cations and anions on carnitine binding to 
human placental brush border membranes 
Salt Camitine binding 
10 min 4 h 
pmol /mg % pmol /mg % 
NaC1 0.17+0.01 100 0.70+0.01 100 
NaF 0.15+0.01 93 0.68+0.01 97 
NaNO3 0.13+0.00 81 0.59-t-0.02 84 
Na SCN 0.14_+0.01 86 0.48+0.01 69 
Na gluconate 0.16+0.01 99 0.92+0.01 131 
LiC1 0.06+0.00 38 0.18+0.00 25 
KC1 0.02 + 0.00 13 0.07 + 0.00 11 
Membrane vesicles were preloaded with 10 mM Hepes-Tris buffer (pH 
7.5), containing 75 mM potassium gluconate and 150 mM mannitol. 
Binding of carnitine (10 nM) was initiated by mixing 40 ILl of membrane 
suspension with 160 Ixl of 10 mM Hepes-Tris buffer (pH 7.5), containing 
indicated inorganic salts (150 mM). The mixture was incubated for 10 
rain or 4 h and bound carnitine was determined by rapid filtration assay. 
Values are means + S.E. (n = 3). 
the incubation time was increased to 4 h to measure the 
Na+-dependent carnitine binding at equilibrium, the bind- 
ing was significantly affected by the anions SCN- and 
gluconate. When compared to the binding measured in the 
presence of CI-, the binding in the presence of SCN- was 
significantly lower whereas the binding in the presence of 
gluconate was significantly higher. Considering the rela- 
tively long incubation time, it is likely that the observed 
effects of SCN- and gluconate are not specific. These data 
show that the binding of carnitine to the placental brush- 
border membrane vesicles exhibits an obligatory require- 
ment for Na ÷ with no or little dependence on anions. 
3.3. Substrate specificity of the carnitine binding process 
To determine the substrate specificity of the binding 
process in the placental brush-border membrane vesicles, 
we performed competition experiments in which the influ- 
ence of various unlabeled substrate analogs on the binding 
of labeled camitine was assessed (Table 2). The binding 
was measured with a 4 h incubation in the presence of 
Na ÷. At a concentration of 100 bM, L-carnitine, D-carni- 
tine, acetyl-DL-carnitine, propionyi-DL-carnitine, palmi- 
toyl-DL-camitine, and betaine inhibited the binding of 10 
nM labeled camitine by 90%. Stearoyl-DL-carnitine was 
slightly less effective, causing 75% inhibition. On the 
other hand, 6-N-trimethyllysine, 13-hydroxybutyrate, ~/- 
aminobutyrate, choline, and creatinine showed very little 
effect on carnitine binding. These results show that the 
binding is specific for carnitine and its acyl derivatives. 
The short-chain as well as long-chain acyl derivatives are 
effective substrates. Among the compounds tudied, be- 
taine was the only non-carnitine compound which effec- 
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Fig. 4. Scatchard analysis of carnitine binding. Human placental brush- 
border membranes were incubated with [3H]carnitine in the presence of 
NaCI for 4 h and bound carnitine was measured by rapid filtration assay. 
The concentration of [3H]carnitine was kept constant at 10 nM in the 
experiment and concentration of carnitine was varied (range, 0.25-25 
p~M) as desired by the addition of unlabeled caruitine. Nonspecific 
binding was determined in the presence of excess amount (1 mM) of 
unlabeled carnitine. Data for specific binding are given as caruitine 
concentration versus binding or as Scatchard plot, i.e., carnitine binding 
(B) versus carnitine binding/carnitine concentration (B/L)  (inset). The 
amount of carnitine bound to the membranes was less than 1% of total 
carnitine present in the incubation mixture at all carnitine concentrations. 
Therefore, concentrations of total carnitine present during incubation 
were used directly in Scatchard analysis. Values are means + S.E. (n = 6). 
tively competed with carnitine for the binding. 6-N-Tri- 
methyllysine, which is the precursor for camitine biosyn- 
thesis, and 13-hydroxybutyrate nd ",/-aminobutyrate, both 
of which bear significant structural resemblance to cami- 
tine, are not recognized by the binding process. Similarly, 
the quaternary ammonium compound choline and the 
guanidino compound creatinine are also not substrates for 
the binding process. 
3.4. Saturation kinetics of carnitine binding 
Fig. 4 describes the influence of carnitine concentration 
on the binding, measured with a 4 h incubation (equi- 
librium binding) in the presence of Na +. The physio- 
logically occurring L-stereoisomer of carnitine was used in 
these studies. The binding was measured over a carnitine 
concentration range of 0.25-25 IxM. Since the amount of 
camitine bound to the membrane vesicles was less than 
1% of total camitine present in the assay medium, the 
concentrations of total carnitine (instead of free carnitine) 
in the medium were used directly in the kinetic analysis. 
Nonspecific binding was determined in the presence of 
excess amount (1 mM) of unlabeled camitine. The rela- 
tionship between specific binding and camitine concentra- 
tion was hyperbolic, demonstrating saturability of the bind- 
ing process. Scatchard analysis of the data provided evi- 
dence for the presence of a single binding site. The 
dissociation constant (K d) for the binding process was 
1.37 _+ 0.03 IxM and the maximal binding capacity (Bmax) 
was 8.0 + 0.1 pmol/mg of membrane protein. 
3.5. Dose-response relationship for the inhibition of 
[3H]carnitine binding by L-carnitine, D-carnitine, acetyl- 
OL-carnitine, and propionyl-oL-carnitine 
The data in Table 2 show that both L- and D-forms of 
camitine are potent inhibitors of [3H]carnitine binding. 
Similarly, the racemic mixtures of the acetyl and propionyl 
esters of camitine are also very effective in inhibiting 
[3H]camitine binding. To determine the relative affinities 
of these four compounds for the carnitine binding process, 
we assessed the ability of increasing concentrations (range, 
0.25-25 IxM) of these compounds to inhibit the binding of 
[3H]carnitine (10 nM). From the dose-response curves, 
given in Fig. 5, it was calculated that the IC50 values 
(concentration of the compound necessary to cause 50% 
inhibition of the specific binding of radiolabeled carnitine) 
for L-carnitine, D-carnitine, acetyl-DL-camitine, and propi- 
onyl-DL-camitine were 0.97 + 0.08 IxM, 1.99 + 0.06 IxM, 
2.63 + 0.28 o~M and 1.26 + 0.16 p~M, respectively. Since 
the concentration of L-[3H]carnitine used in these experi- 
ments was very small compared to the K d value (0.01 p~M 
versus 1.37 t~M), these IC50 values closely approximate o
inhibition constants (Ki). The Ki value calculated for 
L-carnitine (0.97 IxM) is very close to the K d value 
calculated for L-carnitine (1.37 txM) by Scatchard analysis. 
It is evident from the K~ values that the binding process 
exhibits about wo-fold less affinity for D-carnitine than for 
L-carnitine. If this is also true for the stereoisomers of
acetylcarnitine and propionylcarnitine, the actual K i val- 
ues for the L-isomers of these camitine sters are likely to 
be lower than the K~ values determined in this study for 
100 
8O 
?-2_- 40 
m 
0 
2O 
0.1 1 10 100 
[Unlabeled carnitine or its derivatives] (I~M) 
Fig. 5. Dose-response r lationship for the inhibition of [3H]carnitine 
binding to human placental brush-border membranes by unlabeled D- 
carnitine, L-carnitine, acetyl-DL-carnitine, and propionyl-DL-carnitine. 
Binding of [3H]carnitine (final concentration, 10 nM) to placental mem- 
branes was measured with a 4 h incubation in the presence of NaCI. 
Concentration of unlabeled carnitine or its derivatives was varied between 
0.25 and 25 p,M. Binding of [3H]carnitine measured in the absence of 
inhibitors was 0.86+0.07 pmol /mg of protein and this value was taken 
as 100% (control). Values represent means+S.E. (n=4) .  Key: O, 
D-carnitine; O, L-camitine; I ,  acetyl-DL-camitine; rq, propionyl-DL- 
carnitine. The S.E. bars for the 10 and 25 p,M values are within the 
symbol and are not shown for clarity. 
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Fig. 6. Influence of Na + concentration on carnitine binding, Human 
placental brush-border membranes were incubated with 10 nM [3H]carni- 
tine for 4 h in the presence of various concentrations of Na t (as NaCI) 
(range, 5-100 mM). Appropriate concentrations of KC1 were used to 
maintain osmolality. Na+-dependent binding was calculated by subtract- 
ing the binding measured in the absence of Na + from the binding 
measured in the presence of Na t. Values (means + S,E., n = 4) represent 
Nat-dependent binding. Data are presented as [Na t ] versus carnitine 
binding or as a Hill-type plot, i.e., carnitine binding (B) versus caruitine 
binding/[Na ÷] (inset). 
the respective racemic mixtures. The L-isomers of these 
two carnitine sters are currently in therapeutic use [24,25]. 
3.6. Dependence of carnitine binding on Na + concentra- 
tion 
To analyze kinetically the dependence of carnitine bind- 
ing on the concentration of Na +, equilibrium binding of 
carnitine was measured in the presence of increasing con- 
centrations of Na ÷ in the binding buffer (range, 0-100 
mM). The relationship between Na+-dependent carnitine 
binding (i.e., binding in the presence of Na + minus bind- 
ing in the absence of Na +) and Na + concentration was 
found to be hyperbolic (Fig. 6), suggesting a Na÷/carni - 
tine coupling ratio of 1. The data were analyzed using the 
Hill-type equation 
BM[Na+]" 
B= 
K~. 5 + [Na + ]" 
where B is Na+-dependent carnitine binding, B M is carni- 
tine binding at infinite concentration of Na +, K0. s is the 
concentration of Na + necessary to cause carnitine binding 
equal to 50% of B M, and n is the number of Na + ions 
involved in the binding of one molecule of carnitine. This 
analysis gave an n value of 0.95 5:0.08 and K0. 5 value of 
24 -I- 4 mM. The n value is very close to 1 and provides 
supporting evidence for the Na+/carnitine coupling ratio 
of 1 in the binding process. 
3. 7. Influence of Na + on the kinetics of carnitine binding 
Since the binding of carnitine is a Na+-dependent pro- 
cess, it was of interest o determine the influence of Na ÷ 
on the kinetic parameters of carnitine binding. The binding 
of carnitine was kinetically analyzed to calculate the K d 
and Bma x at two different Na ÷ concentrations, 150 mM 
and 20 mM (Fig. 7). At a Na ÷ concentration of 150 mM, 
the K d for carnitine binding was 1.36 + 0.03 IxM and 
Bma x was  9.9 + 0.1 pmol /mg of membrane protein. When 
the concentration of Na ÷ was lowered to 20 mM, the K d 
value for caruitine increased 2-fold to 2.73 + 0.11 IxM. 
There was no significant change in Bma x (10.7 ___ 0.3 
pmol /mg of membrane protein). These results show that 
Na ÷ activates carnitine binding by enhancing the affinity 
of the binding site for carnitine without altering the maxi- 
mal number of binding sites. 
3.8. Carnitine transport/binding in renal and intestinal 
brush-border membrane vesicles 
We compared the handling of carnitine by the human 
placental brush-border membrane vesicles with the han- 
dling of carnitine by brush-border membrane vesicles from 
two other transporting epithelia, namely, the renal and 
intestinal absorptive cells. The time course of carnitine 
association with the renal brush-border membrane vesicles 
in the presence and absence of an inwardly directed Na ÷ 
gradient is described in Fig. 8A. The amount of carnitine 
associated with the vesicles in the absence of Na ÷ was 
small, increased with time, and reached equilibrium within 
60 min. The presence of an inwardly directed Na + gradi- 
ent markedly stimulated the initial rates of carnitine associ- 
ation and the time course under these conditions exhibited 
the 'overshoot' phenomenon that is typical of a Na + 
gradient-dependent transport process. The Na+-dependence 
of the process was evident only with short incubation 
periods. At 60 min incubation, the amount of carnitine 
associated with the membrane vesicles was the same in the 
presence as well as in the absence of Na ÷. These data 
provide evidence for the presence of a Na ÷ gradient-driven 
uphill transport of carnitine in renal brush-border mem- 
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Fig. 7. Influence of Na + on the kinetics of carnitine binding. Human 
placental brush-border membranes were incubated with varying concen- 
trations (range, 0.25-25 p~M) of carnitine in the presence of either 20 
mM NaCI (O) or 150 mM NaCI (0) .  KC1 was used to maintain 
osmolality. Values (means + S.E., n = 4) represent specific binding. Data 
are presented as Scatchard plots, i.e., carnitine binding (B) versus carni- 
tine binding/carnitine concentration (B/L). 
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Fig. 8. Binding/transport f carnitine in rat renal (A) and rabbit intestinal 
(B) brush-border membrane v sicles. Membrane vesicles were preloaded 
with 10 mM Hepes-Tris buffer (pH 7.5), containing 75 mM potassium 
gluconate and 150 mM mannitol. Binding/transport of carnitine was 
initiated by mixing 40 i~1 of membrane suspension (200 ixg of membrane 
protein) with 160 ~1 of 10 mM Hepes-Tris buffer (pH 7.5), containing 
[3H]carnitine and either 150 mM NaC1 (0) or 150 mM KCI (©). The 
mixture was incubated for varying time periods and binding/transport 
was determined byrapid filtration assay. Final concentration f carnitine 
in the incubation mixture was 10 nM in the case of renal membrane 
vesicles and 20 nM in the case of intestinal membrane v sicles. Values 
are averages ofduplicate determinations. 
brane vesicles. At equilibrium with the transmembrane 
Na ÷ gradient no longer in existence, there is no net 
transport of camitine into the vesicles. Accordingly, there 
is no evidence for Na÷-dependence of carnitine transport 
under these equilibrium conditions. Thus, the transport of 
carnitine in response to a transmembrane Na ÷ gradient is 
clearly demonstrable in renal brush-border membrane vesi- 
cles. These characteristics of carnitine transport in renal 
brush-border membrane vesicles differ markedly from those 
of carnitine transport in placental brush-border membrane 
vesicles. 
Fig. 8B describes the time course of the association of 
carnitine with intestinal brush-border membrane vesicles in 
the presence and in the absence of an inwardly directed 
Na + gradient. In contrast o the renal and placental brush- 
border membrane vesicles, there was no Na+-dependent 
association of carnitine with the intestinal brush-border 
membrane vesicles. This shows that there is neither Na +- 
dependent carnitine transport nor Na+-dependent camitine 
binding in the intestinal brush-border membrane vesicles. 
4. Discussion 
In this paper we describe the characteristics of the 
interaction of camitine with purified human placental 
brush-border membrane vesicles. This study was under- 
taken to delineate the mechanism involved in the maternal- 
to-fetal transfer of carnitine across the placenta. There is 
unequivocal evidence for the transfer of carnitine from 
mother to fetus, but the mechanism underlying this transfer 
process has not been identified. Transfer of carnitine across 
the placental syncytiotrophoblast has to involve at least 
two steps - transfer across the maternal-facing brush-border 
membrane, followed by transfer across the fetal-facing 
basal membrane. The purpose of the study reported in this 
paper was to elucidate the mechanism of carnitine trans- 
port in purified brush-border membrane vesicles. The re- 
suits of the study indicate that the human placental brush- 
border membranes bind carnitine in a Na+-dependent man- 
ner. The binding process is substrate-specific, exhibiting 
high-affinity only for carnitine and its acyl (short-chain as 
well as long-chain) derivatives. The requirement of the 
binding process for Na + is absolute. The presence of Na + 
increases the affinity for carnitine. The Na+/carnitine 
coupling ratio appears to be 1. These findings are unique 
because the presence of Na+-dependent high-affinity bind- 
ing of carnitine has not been described thus far in any 
mammalian tissue. 
There have been earlier reports on the handling of 
carnitine by isolated renal [26,27] and intestinal [28] 
brush-border membrane vesicles. Mammalian kidney is 
known to reabsorb carnitine actively from the tubular 
filtrate [29,30] and accordingly the renal brush-border 
membrane vesicles possess the ability to take up carnitine 
in a Na + gradient-dependent manner [26,27]. The charac- 
teristics of interaction of camitine with renal brush-border 
membrane vesicles are as expected for a typical Na + 
gradient-driven transport process. There is no evidence for 
Na+-dependent binding of carnitine in these membranes. 
Intestinal brush-border membrane vesicles were used to 
study carnitine transport [28], prompted by the reports of 
successful treatment of carnitine deficiency with large oral 
doses of carnitine [31,32] and by the findings which sug- 
gested the presence of a Na+-dependent transport mecha- 
nism for carnitine in intact intestinal tissue preparations 
[33-35]. Surprisingly, it was concluded from the study 
with purified intestinal brush-border membrane vesicles 
that these membranes do not possess a Na+-dependent 
camitine transport mechanism. There is also no evidence 
for Na+-dependent camitine binding in these membranes. 
The aforementioned results obtained by other investiga- 
tors with purified renal and intestinal brush-border mem- 
brane vesicles have been confirmed in the present study, 
ruling out any possible contribution of methodological 
differences to the interpretation of the data obtained with 
placental brush-border membrane vesicles. Thus, the pre- 
sent study provides evidence for the first time for Na+-de - 
pendent high-affinity binding of carnitine to human placen- 
tal brush-border membranes. Such binding in the plasma 
membrane has not been described in any other tissue. 
Recently, Vesci et al. [36] reported on the characterization 
of carnitine binding sites in rat brain. These binding sites 
are localized to synaptic vesicles. There are important 
differences between these neuronal carnitine binding sites 
and the placental carnitine binding process. The neuronal 
binding sites appear to be Na+-independent because these 
sites show saturable high-affinity (K d = 0.28 IxM) carni- 
tine binding in the total absence of Na +. Furthermore, the 
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neuronal binding sites are very specific for carnitine. The 
affinity of these sites for acetylcarnitine is 500-fold less 
than that for carnitine. These characteristics are clearly 
different from those of the binding process in the placental 
brush-border membrane. Therefore, the high-affinity carni- 
tine binding described in the present study in human 
placental brush-border membranes are not identical with 
the neuronal carnitine binding. 
It is likely that the Na+-dependent, high-affinity binding 
process pecific for carnitine and its acyl derivatives in the 
brush-border membrane of the human placenta described 
in this paper are involved in the transfer of carnitine across 
the brush-border membrane in the placenta. However, the 
renal brush-border membrane vesicles which transport car- 
nitine into the intravesicular space in a Na ÷ gradient-de- 
pendent manner do not exhibit measurable Na+-dependent 
binding of carnitine. In most cases, this is the normal 
characteristic of a typical ion gradient-driven solute trans- 
porter. Apparently, in placental brush-border membrane 
vesicles, carnitine binds to some component on the internal 
surface of the membrane following Na÷-dependent trans- 
port across the membrane. 
Even though available vidence for active transport of 
carnitine from mother to fetus across the human placenta is 
unequivocal, there is a lot that needs to be understood 
regarding the role of carnitine in fetal development. There 
is very little contribution of fatty acid oxidation to the 
energy needs of the fetus and therefore, building up the 
tissue carnitine reserves to facilitate fatty acid oxidation in 
the immediate postnatal period seems to be an obvious 
function of the placental transfer of carnitine. However, it 
seems unlikely that carnitine has no active role in the 
developing fetus prior to birth. Animal studies have shown 
that untreated carnitine deficiency in the mother during 
pregnancy is associated with severe metabolic derange- 
ment in the newborns that is detectable within 5 days of 
birth [37-39]. These findings were from a genetically 
mutant mouse, called juvenile visceral steatosis (jvs) 
mouse, which exhibits systemic arnitine deficiency most 
likely due to a genetic defect in the renal carnitine trans- 
port system [40]. Facilitation of fatty acid oxidation within 
the mitochondria does not appear to be the only function 
of carnitine in animal tissues. Evidence has been accumu- 
lating in recent years suggesting involvement of camitine 
in other functions such as in the regulation of immune 
response, apoptosis, and oxidative stress [41]. Therefore, it 
is very likely that placental transfer of maternal carnitine 
to the fetus is obligatory for normal growth and develop- 
ment of the fetus in utero, since the developing fetus has 
no or little capacity for endogenous biosynthesis of this 
compound. 
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